These findings led us to examine the sensitivity of both HCT116 and HT-29 cancer cells maintained at pHe 6.5 or 7.4 to selective inhibitors of ATM and ATR kinases, AZD0156 and KU60019 (ATMi) and elimusertib (ATRi), respectively. This evidence concerns the gene ATM and cancer.